The amount of speculative investors on this thread amazes me. Take the guidance for what it is. The risk just isn't worth it.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago